-transparent.png){kind=logo}
In order to study the biological activities of tea preparations and purified tea polyphenols, their growth inhibitory effects were investigated using four human cancer cell lines. Growth inhibition was measured by [3H]thymidine incorporation after 48 h of treatment. The green tea catechins (-)-epigallocatechin-3-gallate (EGCG) and (-)-epigallocatechin (EGC) displayed strong growth inhibitory effects against lung tumor cell lines H661 and H1299, with estimated IC50 values of 22 microM, but were less effective against lung cancer cell line H441 and colon cancer cell line HT-29 with IC50 values 2- to 3-fold higher. (-)-Epicatechin-3-gallate, had lower activities, and (-)-epicatechin was even less effective. Preparations of green tea polyphenols and theaflavins had higher activities than extracts of green tea and decaffeinated green tea. The results suggest that the growth inhibitory activity of tea extracts is caused by the activities of different tea polyphenols. Exposure of H661 cells to 30 microM EGCG, EGC or theaflavins for 24 h led to the induction of apoptosis as determined by an annexin V apoptosis assay, showing apoptosis indices of 23, 26 and 8%, respectively; with 100 microM of these compounds, the apoptosis indices were 82, 76 and 78%, respectively. Incubation of H661 cells with EGCG also induced a dose-dependent formation of H2O2. Addition of H2O2 to H661 cells caused apoptosis in a manner similar to that caused by EGCG. The EGCG-induced apoptosis in H661 cells was completely inhibited by exogenously added catalase (50 units/ml). These results suggest that tea polyphenol-induced production of H2O2 may mediate apoptosis and that this may contribute to the growth inhibitory activities of tea polyphenols in vitro.
G Y Yang, and
J Liao, and
K Kim, and
E J Yurkow, and
C S Yang
June 2005,
Oncology reports,
G Y Yang, and
J Liao, and
K Kim, and
E J Yurkow, and
C S Yang
January 2005,
Asian Pacific journal of cancer prevention : APJCP,
G Y Yang, and
J Liao, and
K Kim, and
E J Yurkow, and
C S Yang
November 1995,
Journal of the National Cancer Institute,
G Y Yang, and
J Liao, and
K Kim, and
E J Yurkow, and
C S Yang
January 2003,
International journal of oncology,
G Y Yang, and
J Liao, and
K Kim, and
E J Yurkow, and
C S Yang
July 1997,
Japanese journal of cancer research : Gann,
G Y Yang, and
J Liao, and
K Kim, and
E J Yurkow, and
C S Yang
May 2000,
Leukemia,
G Y Yang, and
J Liao, and
K Kim, and
E J Yurkow, and
C S Yang
January 2009,
Nutrition and cancer,
G Y Yang, and
J Liao, and
K Kim, and
E J Yurkow, and
C S Yang
January 1997,
Hunan yi ke da xue xue bao = Hunan yike daxue xuebao = Bulletin of Hunan Medical University,
G Y Yang, and
J Liao, and
K Kim, and
E J Yurkow, and
C S Yang
March 2006,
Journal of alternative and complementary medicine (New York, N.Y.),
G Y Yang, and
J Liao, and
K Kim, and
E J Yurkow, and
C S Yang
June 2010,
Investigational new drugs,
